Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability

Circulation

Volumn 104, Issue 8, 2001, Pages 921-927

  Cipollone, Francesco ^a   Prontera, Cesaria ^a   Pini, Barbara ^a   Marini, Matteo ^a   Fazia, Maria ^a   De Cesare, Domenico ^a   Iezzi, Annalisa ^a   Ucchino, Sante ^a   Boccoli, Gianfranco ^a   Saba, Vittorio ^a,b   Chiarelli, Francesco ^a   Cuccurullo, Franco ^a   Mezzetti, Andrea ^a,c  

^a UNIVERSITY OF CHIETI   (Italy)

^b INRCA   (Italy)

^c Centro per la Prevenzione dell'Aterosclerosi   (Italy)

Author keywords

Atherosclerosis; Inflammation; Metalloproteinases; Plaque; Prostaglandins

Indexed keywords

CYCLOOXYGENASE 2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE ACTIVATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 0035928784     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3401.093152     Document Type: Article

References (27)

1. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
2. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
3. Inflammation in high-grade carotid stenosis: A possible role for macrophages and T cells in plaque destabilization
4. Neutral metalloproteinases produced by human mononuclear phagocytes: Enzyme profile, regulation and cellular differentiation
5. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
6. Increased matrix-metalloproteinase-9 activity in unstable carotid plaques: A potential role in acute plaque disruption
7. 2, and matrix metalloproteinases production by human monocytes
8. Yes, but do they still get headaches?
9. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina
10. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions
11. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target
12. Secretion of metalloproteinases by stimulated capillary endothelial cells, I: Production of procollagenase and prostromelysin exceeds expression of proteolytic activity
13. Monocyte prostaglandins inhibit procollagen secretion by human vascular smooth muscle cells: Implications for plaque stability
14. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
15. Atherosclerotic carotid disease in asymptomatic individuals: A histology study of 53 cases
16. Cyclooxygenase-1 and 2-dependent prostacyclin formation in patients with atherosclerosis
17. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages
18. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
19. 2 synthase in human monocytes
20. 2 synthesis, and cyclooxygenase expression in abdominal aortic aneurysms
21. Proinflammatory cytokines regulate cyclooxygenase-2 expression in human macrophages
22. 2 synthase that acts in concert with cyclooxygenase-2
23. 2 in lipopolysaccharide-stimulated rat peritoneal macrophages
24. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: Regulation by dexamethasone
25. Fatty acids and their prostaglandin derivatives: Inhibitors of proliferation in aortic smooth muscle cells
26. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells
27. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice